IL10 and COVID-19: Receptors for type I (IFNAR1 and 2) and III (IL10RB) interferons drive inflammation mediated by NK and CD8+ T cells, and IL-10RB binds IL-10 whose levels are a severity predictor in COVID-19 [62] (Fig. 5B).